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ABSTRACT 
 
Background: Hormonal contraceptive contains estrogen and progesterone hormones. These 
hormones are hypothesized to affect blood glucose level. This study aimed to determine the 
association between hormonal contraception and blood glucose level among childbearing aged 
women. 
Subjects and Method: This was an analytic observational study with cross-sectional design. The 
study subjects were childbearing aged women who used and did not use hormonal contraceptive in 
Sangkrah community health center, Surakarta. A total sample of 47 people consisting of 32 
hormonal contraceptive users and 15 non users were selected for study by fixed exposure sampling. 
The data were collected by questionnaire, interview, anthropometric measurement, and direct 
measurement of blood glucose level. The data were analyzed using a multiple linear regression with 
SPSS for Windows. 
Results: Women of childbearing age who used hormonal contraceptive had an average blood 
glucose 26 mg / dL higher than the non-users of hormonal contraceptive (b= 26.18; 95% CI= 15.03 
to 37.33; p <0.001). These estimates had controlled for the effect of confounding variables (i.e. Body 
Mass Index and diabetes mellitus risk factors). 
Conclusion: There is a positive and statistically significant association between the use of 
hormonal contraceptive and blood glucose level among women of childbearing age. 
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BACKGROUND 
Human population growth is getting in-
creasing. By the end of 2012 it is recorded 
that the world population has reached 7 
billion people, whereas Indonesia is in the 
4th place after China, India, and USA (Biro 
Pusat Statistik, 2013). The high population 
growth rate of a country certainly is follow-
ed by its advantages and disadvantages. The 
advantage is the higher number of human 
resources will strengthen national defense.  
Indonesia will be a developed country for 
sure if the resource can be well managed 
However, a large number of human resour-
ce is also followed by a large number of de-
mography problems. 
To make the best use of Human re-
source management in Indonesia, therefore 
government finds it necessary to anticipate 
the occurrence of population explosion. Fa-
mily Planning program or Keluarga Beren-
cana (KB) is an effort to control population 
desity by lowering down the fertility rate 
using contraceptive (Glasier dan Gebbie, 
2006). The program is positively responded 
with the emerging of Indonesian people’s 
awarness to participate in KB program. Cen-
tral Bureau of Statistics states that in 2011 
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the percentage of married women aged 15-
49 who used contraceptives was 61.34%, it 
increased from 2010 that was only 60.94% 
(Biro Pusat Statistik, 2012). 
Currently there are various types of 
contraceptives methods such as IUD, sterili-
zation, condome, hormonal contraceptive 
either injected, oral/ pill, or implant. The 
most used method of contraceptive is hor-
monal contraceptive. Users of hormonal con-
traceptives in Indonesia based on National 
Dempography and Family Planning Agency 
(BKKBN) is 83.29% in January 2012. The 
most commonly used hormonal contracep-
tives are injection 48.72%, oral/ pill 27.72%, 
implant 6.85%. In Central Java, users of 
hormonal contraceptives reach 86.35%, and 
56.33% of them use injection method, 19.91% 
use oral method/ pill, and 10.11% use contra-
ceptive implant (BKKBN, 2012). Hormonal 
contraceptives are mostly used because it is 
easy to get, widely varied, highly effective 
(Wiegratz dan Christian, 2011).  
Hormonal contraceptives are distingu-
ished based on their hormone content into 2 
categories namely combined contraceptives 
(with estrogen and progesterone content) 
and progesterone contraceptives. Progeste-
rone contraceptives are likely to be develo-
ped since a number of side effects are ge-
nerated from contraceptives with estrogen  
(Ahrendt dan Bühling, 2010). However, the 
effect of progesterone contraceptives also 
needs further study, since progesterone 
shows antagonist nature toward insulin so it 
may increase blood glucose level (Chrousos, 
2007). Therefore, the writer is interested to 
analyze the correlation between hormonal 
contraception and blood glucose level. 
 
SUBJECTS AND METHOD 
The study was an analytic observational stu-
dy with cross-sectional study approach. The 
study was employed to investigate the asso-
ciation between study factors by simultan-
eously observing those factors on indivi-
duals of single population within one period 
of time (Murti, 2003). Certainly, not all sub-
jects should be assessed on the same day or 
time, however the factors to be investigated 
are measured according to condition or 
status of observation time (Sastroasmoro, 
2008) 
The study was conducted during April 
and May 2013 in Sangkrah Community 
Health Center Surakarta. The place of study 
was chosen because Sangkrah Community 
Health Center covers the most number of 
people in the area of Surakarta city which 
subordinates 3 urban communities: Sang-
krah, Kedung Lumbu, and Semanggi urban 
communities. 
The targeted population was women of 
childbearing age who took hormonal con-
traceptives in Sangkrah Community Health 
Center Surakarta. The accessible population 
was women of childbearing age in Sangkrah 
Community Health Center Surakarta. The 
population of women of childbearing age 
who took hormonal contraceptives in Sang-
karah Community Health Center Surakarta 
by the end of 2012 was 3,040 people out of 
totally 5,333 contraceptives users. Therefore 
it was exceedingly sufficient for collecting 
sample in the location. 
The sample was women of childbear-
ing age who took hormonal contraceptives 
in Sangkrah Community Health Center Su-
rakarta who were willing to be assessed, 
with the following criteria: 
a. Inclusion Criteria: 
1) Women of childbearing age (not yet me-
nopause) 
2) Age 20-49 years old 
According to PERKENI consensus 2006, the 
assessment of diabetes mellitus risk factors 
is conducted toward people aged 20 years 
old and above. The IMT is a nutrition status 
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assessment conducted to those who age 
more (Depkes, 2008). Menopause happens 
commonly in the age 50 years old. Consider-
ing that it was determined that the sample 
age ranged from 20-49 years old.  
3) Users of hormonal contraceptives and non 
users of hormonal contraceptives as control 
group. 
4) The users of hormonal contraceptives 
have been using it for at least 3 months in 
the past year 
5) Are willing to be research subjects and 
sign an informed consent. 
6) Are willing to be interviewed for the sake 
of data collection. 
b. Exclusion Criteria : 
1) Diabetes mellitus positive patients based 
on doctor’s diagnosis before using contra-
ception  
2) Have suffered from gestational diabetes 
mellitus based on doctor’s diagnosis (gave 
birth to a baby weigh  >4 kg) 
3) Having history of blood glucose problem 
(>200 mg/dL). 
OGTT examination result is 140-199 mg/dL 
or impaired fasting glucose is 100-125 mg/ 
dL that indicates impaired glucose tolerance  
4) Smoking and drinking alcohol. 
Cigarette and alcohol may reduce insulin 
sensitivity and increase the occurrence of 
insulin resistance 
5) Long term drug consumption. 
Antidiabetic drugs consumption may reduce 
blood glucose level. Cortisone and Thiazide 
may increase blood glucose level. 
6) Not willing to participate as research sub-
jects 
Sample collection was conducted by using 
purposive random sampling based on in-
clusion and exclusion criteria toward hor-
monal contraceptives acceptors who visit 
Sangkrah Community Health Center Sura-
karta. Sample collection by using this me-
thod is conducted to obtain sample that 
represents characteristics of targeted popu-
lation and controlled confounding factor 
which is both indentified and unidentified 
by researchers on the stage of research sub-
jects’ selection. Sample is someone who has 
agreed on informed consent. 
The study employed multivariate ana-
lysis. The number of sample is obtained 
from the ratio of sample size and number of  
independent variables, with: 
 
 
 
N = Number of samples 
There are three independent variables that 
are taken into account, namely hormonal 
contraceptive use, diabetes mellitus risk 
factors and body mass index. So that,  
 
 
The samples needed for the study are as 
many as 45 up to 60 subjects  (Murti, 2003). 
1. Independent variable : The use of hor-
monal contraceptives 
2. Dependent variable : Blood glucose level 
3. Confounding variables :  
a. Body Mass Index (BMI) 
b. Diabetic Mellitus risk factors 
1) Physical activities 
2) Food and drink intake/ diet pattern 
3) Genetic factors/ family history  
4) Weight at birth < 2,5 kg 
Operational Definitions 
1. The use of Hormonal Contraceptives 
a. Definition: the use of contraceptive types 
that contains estrogen and progesterone, in 
the form of injection, pill, as well as implant. 
The contraceptives have been used for the 
last three months and have not yet been 
substituted with other type of contraceptive 
within the period of time, since impaired 
glucose tolerance usually emerges after 3 
months of use (Hilal, 1985). 
N = 15-20 subjects per independent variable 
 
N = 15-20 subjects x 3 independent variables  
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b. Measuring instrument: questionnaires 
with structured interview 
c. Measuring scale: nominal 
Criteria: users, hormonal contraceptives, 
more than 3 months 
1 = yes ; 0 = no 
2. Blood Glucose Level 
a. Definition: the amount of glucose mea-
surement which is the final result of carbo-
hydrate digestion in human body meta-
bolism within blood. Respondents’ blood 
glucose level which is measured is random 
blood glucose level 
b. Measuring instrument: Easy Touch Blood 
Glucose Test Meter which is equipped with 
glucostrip dan chip. The capillaries blood 
sampling is conducted on finger tip (that 
previously has been cleansed with alcohol) 
by using lancet.  
c. Measuring scale: ratio is presented in 
mg/ dL 
3. Body Mass Index (BMI) 
a. Definition: body mass index is an illus-
tration of one’s nutrition status. 
It is measured through formula body weight 
in kilogram divided by body height in meter 
square. 
b. Measuring instrument: weight scales and 
height scales 
c. Measuring scale: ratio is presented in kg/ 
m2 
4. Diabetes Mellitus Risk Factors 
a. Physical activity 
Definition: Physical activities that affect 
blood glucose level are heavy up to medium 
type of physical activities and exercises. It is 
conducted at least 30 minutes within a day 
and three times a week. Examples of some 
heavy up to medium physical activities are 
washing clothes, sweeping, ironing, garden-
ing, cleaning windows, walking 3,5 mil/ 
hour, driving car, painting house, and cut-
ting wood (Depkes, 2008).  
Measuring instruments: questionnaires with 
structured interview 
Measuring scale: nominal  
Criteria: 30 minutes/activity, 3x activities/ 
week, regular 
0 = yes ; 1 = no 
b. Food and drink intake/ diet pattern 
Definition: good food and drink intake is the 
one that high in fiber and low in sugar. 
Three times of big meal (breakfast at 06.00-
08.00, lunch at 12.00-13.00, and dinner at 
18.00-19.00) added with three times of 
snacks to prevent stomach diseases. In diet  
assessment toward society it prioritizes more 
on vegetables and fruit consumption as 
much as 3–4 portion a day, and granulated 
sugar is 2–3 spoons a day (Depkes, 2008). 
Measuring instruments: questionnaires with 
structured interview 
Measuring scale : nominal 
 Meals in a day 
Criteria :  3x big meals + 3x snacks 
 Fruits/vegetables consumption  
0 = yes ; 1 = no 
 Granulated sugar consumption 
Criteria : >3 tablespoon 
1 = yes ; 0 = no 
Then the three of them are summed up and 
categorized by dichotomy: 
Sum  2  1 = ya ; < 2  0 = tidak 
c. Birth weight< 2500 gram 
1 = yes ; 0 = no 
Someone who was born with Low Birth We-
ight <2500 gram is possible to have pancre-
as damage so that pancreas capability to 
produce insulin will be disrupted (Depkes, 
2008) 
d. Genetic factors/ family history 
Criteria : grandmother, grandfather, father, 
mother, brother, and  sister, 
1 = yes ; 0 = no 
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Research Instruments 
1. Questionnaire sheets that includes In-
formed Consent, data of respondents, and 
questions to assess the research variables. 
2. Body weight scales and body height 
scales 
3. Equipments for blood glucose examinat-
ion (Easy Touch Blood Test Meter, Gluco-
strip, alcohol 70 %, kapas, lancet) 
Procedures: 
1. Anamnesis samples which fit research 
criteria. 
2. Describe it in general about the purpose, 
benefits, and procedures of the research, in-
cluding explain that the writer will keep the 
confidentiality of identity and results ob-
tained. 
3. Ask the research subjects to sign inform-
ed consent as a statement of willingness to 
participate in the study. 
4. Ask the research subjects to fill out qu-
estionnaires and conduct structured inter-
view to identify the identity, obtain the his-
tory of birth control use, and other factors. 
5. Carry out body weight and body height 
measurement to calculate BMI 
6. Measure the level of random blood glu-
cose (RBG) 
7. Process and analyze the data obtained 
Data Analysis Technique 
The obtained data were analyzed statis-
tically by using multiple linear regression 
model multivariate analysis with Statistical 
Product and Service Sollution (SPSS) for 
windows. This type of analysis is employed 
to discover the form of association among 
variables by controlling the confounding 
factors to minimize the possibility of wrong 
conclusion. 
The formula :    
 
 
Information : 
Y = Blood glucose level (mg/dL) 
a =  constant 
b1 = regression coefficient for the use of 
hormonal contraceptives 
x1   = the use of hormonal contraceptives 
    (0=No;1=Yes) 
b2 = regression coefficient for BMI 
x2 = body mass index (kg/m2) 
b3 =regression coefficient for diabetes melli-
tus risk factors 
x3   = diabetes mellitus risk factors 
    (0=No;1=Yes) 
Interpretation : 
b = 0   no association 
b > 0   positive association 
(Increase blood glucose level) 
b < 0  negative association  
(decrease blood glucose level) 
 Characteristics of categorical data 
sample were described in frequency (n) and 
percentage (%), whereas characteristics of 
continue data sample were described in 
mean, standard deviation (SD), minimum, 
and maximum. Statistical significance of 
each correlation coefficient (regression b 
coefficient) is tested afterward with t test 
and the result is presented by p value. 
(Murti, 2003) 
 
RESULTS 
General Description of the Study 
The working area of Sangkrah Community 
Health Center covers Semanggi, Sangkrah 
and Kedung Lumbu urban communities. 
According to community health center’s re-
cord by the end of 2012 the total number of 
active birth control acceptors was as 5,333 
people out of 6,622 couples of childbearing 
age. Afterward, sample was taken from the 
population that was women of childbearing 
age who met the criteria of research sample 
and agreed with inform consent. It obtained 
32 acceptors of hormonal contraceptives 
and 15 women of childbearing age who did 
abxbx+b3x3 
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not take hormonal contraceptives as control 
group. 
Research Subjects Characteristics 
1. Research Subjects’ Age 
From the data obtained, it was discovered 
that the age of research subjects were vari-
ed. The youngest was 20 years old, and the 
oldest was 49 years old. It was in accord-
ance with inclusion exclusion criteria that 
obliged the sample should be women of 
childbearing age (not yet menopause) the 
ages were between 20 up to 49 years old. 
Sample of hormonal contraceptives users 
were between 24-49 years old, whereas for 
control group were 20–40 years old. The 
number of subjects who were <35 years old 
were 28 people (59.57%) and those who 
were ≥35 years old were 19 subjects (40. 
43%). The average age of research subjects 
on hormonal contraceptives acceptors was 
34 years and on control group was 29 years.  
2. Occupation Distribution 
Occupation of the research subjects was 
assessed by using simple open question to 
discover how their daily physical activities. 
From the result of data collection it was 
found that the frequency of housewives 
were 28 people (59.6%), civil servants were 
6 people (12.8%), labors were 5 orang 
(10.6%), dan private sectors were 8 orang 
(17%). 
All research subjects admitted that 
they did not carry out heavy physical acti-
vities before the examination and almost 
every household chore was conducted by 
themselves such as washing clothes, sweep-
ing, mopping, babysitting, and others, how-
ever they never exercised and always rode 
motorized vehicle anywhere to go. 
3. Level of Education 
The level of education of hormonal contra-
ceptives users was varied. It ranged from 
primary school to undergraduate degree. 
From the result of data collection it was 
discovered that those who were educated up 
to Primary school were 12 people (25.5%), 
Secondary school were 10 people (21.3%), 
High school 17 people (36.2%), Diploma 
degree 4 people (8.5%), and Bachelor de-
gree 4 people (8.5%). 
The existing data showed that the high-
est frequency was High school and the low-
est frequency was diploma and bachelor de-
gree. 
4. The Use of Contraceptives 
From Table 1 data it can be observed 3 
monthly contraceptive injections was the 
most favored by hormonal contraceptives 
users. The following was the list of contra-
ceptives type used by the research sample  
Table 1. Type of contraceptives used  
 
5. Nutrition Status of Research Subjects 
In the study the result of BMI was obtained 
from calculation: 
BMI = BW/BH2 
Information: 
BMI= Body Mass Index (kg/m2) 
BW = Body weight (kg) 
BH   = Body Height (m) 
Body weight and body height were obtained 
based on direct measurement by using body 
scales and microtoise during the meeting 
between the researchers and the research 
subjects.. 
From the result of the study it was 
discovered that hormonal contraceptives 
users were as many as 32 people that in-
Type of Contraceptives Used Number 
IUD 4 
Condome 1 
Pill 3 
Spiral model 2 
Monthly Injection 5 
3 Monthly Injection 23 
Implant 1 
Do not used any contraceptive 8 
Hormonal Contraceptives 32 
Non-Hormonal Contraceptives 15 
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cludes 20 people with normal BMI (18.5– 
24.9) and 12 people were overweight (>25) 
with average BMI was 24.7 out of the amo-
unt of 19.2 up to 42.4. whereas in control 
group consisted of 15 people, 10 people with 
normal BMI and 5 people were overweight 
with the average BMI was 24.2 out of the 
amount of 19.8 up to 37.1. 
As a whole the research subjects who 
had normal BMI were 30 people out of se-
lected sample, the rest were 17 people and 
included into overweight category. The ave-
rage BMI of research subjects both hor-
monal contraceptives acceptors and control 
group were included in normal limit cri-
teria. The smallest BMI in the study was 
19.2 and the biggest BMI was 42.4 kg/ m2. 
 
6. Diabetes Mellitus Risk Factors 
 
Table 2. Diabetes Mellitus Risk Factors 
DMRF Frequency Percentage 
Cigarette and 
alcohol 
consumption 
History of 
previous diseases  
Drugs 
Consumption 
History of 
impaired blood 
glucose 
History of 
delivering baby 
weighed > 4kg 
History of 
gestational 
diabetes 
Birth weight< 
2,5kg 
Family history of 
diabetes mellitus 
Diet (eating 
pattern) > the 
needs 
Insufficient 
physical activities  
0 
 
 
0 
 
0 
 
0 
 
 
0 
 
 
0 
 
 
2 
 
10 
 
11 
 
 
4 
0% 
 
 
0% 
 
0% 
 
0% 
 
 
0% 
 
 
0% 
 
 
7.4% 
 
37% 
 
40.8% 
 
 
14.8% 
 
Total 27 100% 
 
7. Blood Glucose Level 
Blood glucose level of the research subjects 
was varied. The average blood glucose level 
of hormonal contraceptive users was  86.28 
mg/ dL. The highest level of blood glucose 
was 130 mg/ dL whereas the lowest was 42 
mg/ dL. 
Analysis on Intervariable Association  
The analyzed independent variable was 
hormonal contraceptives use, whereas the 
dependent variable was blood glucose level. 
Statistical test which was employed was 
double linear regression test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Picture 1. Boxplot Blood Glucose Analysis 
of relationship between variables 
 
Table 3. The result of data analysis by 
using double linear regression test.  
 
From Table 3 it is observed that dia-
betes mellitus risk factors with the biggest 
number is diet/eating pattern that exceeds 
Independen 
variables 
Koef b 
ci 95% 
p Lower 
limit 
Upper 
limit 
Hormonal 
Contraceptives 
26.18 15.03 37.33 
<0.001 
DMRF 
BMI 
0.55 
1.38 
-10.00 
0.26 
11.10 
2.51 
0.917 
0.017 
N Observed 47 
Adjusted R2 0.38 
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body needs. The second factor with also big 
number is family history/ genetic factor.  
Adjusted R Square = 0.38 means that 
the use of hormonal contraceptives and 
diabetes mellitus risk factor simultaneously 
are able to define the variation of blood 
glucose level as much as 38%. Table 3. 
shows that there is a positive association 
and statistically significant between hor-
monal contraceptives use with the increase 
of blood glucose level. Women of child 
bearing age who take hormonal contra-
ceptives averagely have blood glucose which 
is 26mg/dl higher than those who do not 
take hormonal contraceptives (b= 26.18; CI 
95%= 15.03 to 37.33) p<0.001). The esti-
mation of the association has controlled the 
effect of diabetes mellitus risk factor. 
 
DISCUSSION 
The study entitled “Association between  
Hormonal Contraception with Blood Gluco-
se Level among Women of Childbearing Age 
in Sangkrah Community Health Center Su-
rakarta” had been conducted in March- May 
2013. Sample was women of Childbearing 
Age who met the criteria and agreed with 
the informed consent. Based on the method 
it found 32 users of hormonal contracep-
tives and 15 women of childbearing age who 
did not use hormonal contraceptives as con-
trol group. So that the total number of sam-
ple was 47 people. 
Age distribution of research subjects 
was varied with the youngest was  20 years 
old and the oldest was 49 tahun. It is in 
accordance with inclusion exclusion criteria 
of the study that obliged sample should be 
women of childbearing age (not yet meno-
pause) whose age ranged from 20 years old 
to 49 years old. The age of research subjects 
was limited on women of child bearing age 
since menopause women no longer have 
estrogen and progesterone hormone, it is 
likely to disturb metabolism. 
It can be concluded from the occu-
pation distribution of research subjects that 
most of the research subjects were house-
wives. However the other occupations were 
also very varied. It was similar to the distri-
bution of research subjects’ level of edu-
cation. 
Table 1. is a table for types of contra-
ceptives used by contraceptives acceptors in 
Sangkrah community health center. It was 
suitable with BKKBN data that the most 
used hormonal contraceptive is 3 monthly 
injection. It happens because of support 
from the government of Indonesia that pro-
motes Family Planning program for free. 
BMI was an illustration of nutrition 
status of the research subjects. It can be 
seen that the majority of hormonal contra-
ceptives users had normal BMI. However, in 
Table 3 actually BMI has significant role to 
influence blood glucose level on women of 
childbearing age, shown with p= 0.017. In 
other words it is not only hormonal contra-
ceptives that can increase blood glucose 
level, but also body mass index can, al-
though the significant value is still below the 
use of hormonal contraceptive which is p< 
0.001. 
On diabetes mellitus risk factors, it is 
seen that out of numerous factors, diet/ 
eating pattern has the highest score. It may 
illustrate that diabetes mellitus is mostly 
caused by the effect of one’s diet/ eating 
pattern, and then is followed by diabetic 
family history, which is a genetic factor. 
Table 3 is a result of data analysis by using 
SPSS with double linear regression. It is 
possible to compare that among the three 
independent variables above the biggest 
significance value to increase blood glucose 
level is hormonal contraceptives with  Ad-
justed R Square= 0.39 it means that the 
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variable of hormonal contraceptives use and 
diabetes mellitus risk factors collaboratively 
are able to define the variation of blood 
glucose level as much as  39%. There is a 
positive relationship and statistically signifi-
cant between the use of hormonal contra-
ceptives and the increase of blood sugar 
level. Women of childbearing age in average 
have 26 mg/dL higher than those who do 
not use hormonal contraceptives (b=26.18; 
CI 95% 15.03 up to 37.33; p<0.001). It is in 
accordance with the theory stated by Chrou-
sos in 2007 that progesterone shows anta-
gonist nature toward insulin, therefore the 
effect of progesterone contraceptives toward 
metabolism still needs a lot more studies. 
Progesterone treatment also may reduce 
insulin sensitivity (Nieuwenhuizen, 1998). 
Hormonal contraceptives formulation with 
high dosage of progesterone will show ab-
normal glucose tolerance test on the users 
(Stubblefield,  2007). 
Various clinical observation and expe-
riment data show that insulin, estrogen, and 
progesterone interact to each other to affect 
carbohydrate metabolism on the level of 
glucose transportation (Valdes dan Elkind-
Hirsch 1991). 
Estrogen induces glucose tolerance 
because of direct effect of estrogen to pan-
creas, in which specific estrogen receptor 
has been identified, however the effect re-
gression can not be explained yet.  Glucose 
level reduction from estrogen effect may 
happen because of the reduction of gluco-
genolysis effect and from glucogeneogenesis 
within cell so that it leads to the increase of 
liver gluconeogenesis. Estrogen hampers 
the induction of glucagon secretion because 
of arginine (Hilal, 1985).  
The increasing level of estrogen and 
progesterone hormones on women who use 
oral combination of hormonal contracep-
tives therapy may influence glucose toleran-
ce and insulin sensitivity (Godsland et al. 
1992).  
For risk factors of coefficient b dia-
betes mellitus the result is positive, it means 
the association which is established between 
diabetes risk factors and blood glucose level 
is positive, meaning to say that if there is 
risk factors of diabetes mellitus then blood 
glucose level will increase as much as 0.6 
mg/dL. However the result of the study was 
not statistically significant since the signify-
cant value was too big which was above 0.05 
(with p= 0.917).  
The study has some limitation those 
are data collection on general condition of 
the respondents were only obtained from 
interview without any verification, and body 
weight, body height and blood glucose level 
examination were only conducted once, 
therefore it was possible to represent not 
the real condition. It happened due to limit-
ed time. The number of respondents had 
met the calculation on sample formulation, 
however by using bigger sample it is expect-
ed that the study result may reduce the bias 
and is able to represent more on the popu-
lation so it is possible to be generalized. 
Therefore it needs to conduct bigger study 
with more number of samples. 
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